Omnicom Health Market Access

We're thrilled to share that our SVP, Group Creative Director, Ricardo Paredes, has been selected as a juror for the 2026 MM+M Awards! Ricardo's creative vision and deep expertise in healthcare make him an incredible addition to this year's panel, and we can't wait to see him help recognize the best work in our industry. Congrats, Ricardo! #MMMawards #Marketaccess #Pharma #Healthcare #Agency

The session "Medically Integrated Oncology Care: Evolving Approaches to Patient-Centered Care" at Asembia this week highlighted something worth paying attention to. The Medically Integrated Pharmacy model is proving that when clinical, pharmacy, and access teams work within one coordinated system, patients win and so do manufacturers. Lower abandonment rates, less medical spend waste, faster access, and less strain on field teams. That is the kind of access strategy OHMA helps clients build. Reach out to learn more: OHMarketAccess@omnicomhealthgroup.com #Asembia2026 #Asembia #AXS26 #MarketAccess #Pharma #Healthcare #Oncology

What a wonderful evening celebrating Kylie J. Wagner at the MM+M Pinnacle Awards! Her lasting impact on the healthcare industry is so well deserved of this honor. Congratulations, Kylie! Read more here: https://lnkd.in/eaE6Ub_Y #healthcare #marketaccess #pharma #mmmpinnacleawards

Cell and gene therapies are expanding fast, and health systems are feeling the financial pressure. A session our team attended at Asembia this week, "Cracking the Code Without Breaking the Bank: Mastering High-Cost Drug Management," showed how Mayo Clinic is getting ahead of it. The takeaway for manufacturers: the partnership models that worked before will not be enough. Balancing innovation, access, and financial sustainability requires a new approach. Helping clients navigate that is the work we do at OHMA. Reach out to learn more: OHMarketAccess@omnicomhealthgroup.com #Asembia #Asembia2026 #AXS26 #MarketAccess #Pharma #Healthcare #CellAndGeneTherapy

Rare disease innovation is outpacing traditional evidence generation. A session our team attended at Asembia, "Optimizing Impact: Exploring Evidence and Outcomes Partnerships in Action," spotlighted how HSSPs are stepping up, evolving beyond distribution into strategic evidence and access partners with the proximity to patients, data, and care delivery to make RWE collaborations work. Shaping that strategy and telling the right story is where OHMA comes in. Reach out to learn more: OHMarketAccess@omnicomhealthgroup.com #Asembia2026 #Asembia #AXS26 #MarketAccess #Pharma #Healthcare #RareDisease #RWE

On Sunday, May 17, 2026, I am proud to be joining thousands at the AIDS Walk New York in Central Park, representing Omnicom Health Market Access, to raise funds supporting people affected by HIV/AIDS.   No one should be without access to HIV/AIDS care, yet many still are. Access to treatment, prevention, and support services can change lives, and I’m hoping to help expand that reach! This event supports the work of GMHC, a leading provider of HIV/AIDS care, prevention, and advocacy in NYC. As the world’s first HIV and AIDS service organization, delivering essential services including testing, nutrition, legal support, mental health care, and education, while also advocating for stronger public policies at the local, state, and federal levels.   I’ve set a fundraising goal of $2,000, and any support would be greatly appreciated: https://lnkd.in/eqZHMRuU

“Health System Specialty Pharmacy as a Care Management Platform to Support Value-Based Care" was a session worth catching at Asembia this week. When HSSPs are integrated into value-based care models, they deliver real results for complex, chronic patients: better adherence, fewer ED visits, lower total medical costs. For manufacturers, this opens up a new way to think about specialty pharmacy partnerships, and shaping that strategy is the work we do at OHMA. Reach out to learn more: OHMarketAccess@omnicomhealthgroup.com #Asembia2026 #Asembia #AXS26 #MarketAccess #Pharma #Healthcare #Specialtypharmacy

"The Current State of Rare Disease Therapeutics" was a key session at Asembia. With 100 new treatments expected in the next 5 years, payers and employers are feeling the cost pressure, and the data demands are shifting. Payers want a simpler, more focused story. And OHMA can help tell that story.   Reach out to learn more: OHMarketAccess@omnicomhealthgroup.com #Asembia2026 #Asembia #AXS26 #MarketAccess #Pharma #Healthcare #Raredisease

Our team kicked off #Asembia 2026 by attending a session on the expanding psoriasis treatment landscape and the evolving role of pharmacists in improving patient access and outcomes. Read our recap below. Want to talk through what this means for your brand? Let's connect: OHMarketAccess@omnicomhealthgroup.com #asembia2026 #axs26 #marketaccess #pharma #healthcare 

The news is out and it’s official: OHMA has won the Manny for Best Market Access Campaign! We couldn’t be more grateful or proud of the work we get to do every day. #mannyawards #marketaccess #pharma #healthcare Med Ad News